We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Trade smarter, not harder: Unleash your inner pro with our toolkit and live discussions.
The current PCVX market cap is 6.91B. The company's latest EPS is USD -3.7107 and P/E is -17.17.
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -58.58M | -86.57M | -71.19M | -87.15M | -113.03M |
| Net Income | -57.92M | -78.05M | -60.46M | -68.34M | -92.66M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Revenue | 0 | 0 | 0 | 0 |
| Operating Income | -89.58M | -103.67M | -232.26M | -468.04M |
| Net Income | -89.22M | -100.08M | -223.49M | -402.27M |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Total Assets | 412.07M | 1.01B | 1.01B | 1.5B | 1.5B |
| Total Liabilities | 52.75M | 52.57M | 63.39M | 69.44M | 93.34M |
| Total Equity | 359.31M | 953.61M | 944.77M | 1.43B | 1.4B |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Total Assets | 392.83M | 324.34M | 1.01B | 1.41B |
| Total Liabilities | 46.98M | 40.32M | 52.57M | 167.45M |
| Total Equity | 345.84M | 284.02M | 953.61M | 1.24B |
| Quarter End | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 |
|---|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | ||
| Operating | -105.38M | -170.6M | -47.69M | -110.43M | -167.98M |
| Investing | 110.54M | 74.59M | -448.1M | -781.67M | -759.39M |
| Financing | 204.81M | 861.55M | 41.56M | 588.53M | 637.08M |
| Year End 31 December 2023 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|
| USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
| Operating | -46.63M | -121.39M | -170.6M | -296.79M |
| Investing | -1.11M | -212.31M | 74.59M | -773.31M |
| Financing | 374.87M | 17.8M | 861.55M | 639.81M |
| Market Cap | 6.91B |
| Price to Earnings Ratio | -17.17 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 17.38 |
| Price to Book Ratio | 5.57 |
| Dividend Yield | - |
| Shares Outstanding | 108.41M |
| Average Volume (1 week) | 773.86k |
| Average Volume (1 Month) | 704.44k |
| 52 Week Change | 32.12% |
| 52 Week High | 82.04 |
| 52 Week Low | 44.20 |
| Spread (Intraday) | 16.08 (20.44%) |
| Company Name | Vaxcyte Inc |
| Address |
corporation trust center wilmington, delaware 19801 |
| Website | https://www.vaxcyte.com |
| Industry | biological pds,ex diagnstics (2836) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions
Hot Features
Premium
